ArticleFrontiers in pediatrics2026

Infliximab for intravenous immunoglobulin-resistant Kawasaki disease complicated with cholestatic hepatitis: a case report and discussion on coronary artery aneurysm prevention.

Zhong Yongxing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.